T1	Participants 28 112	Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
T2	Participants 272 296	acute coronary syndromes
T3	Participants 359 434	patients with high residual platelet reactivity (HRPR) i.e. poor responders
T4	Participants 1139 1164	44 patients were enrolled
